The US Food and Drug Administration (FDA) is planning to regulate the use of the cannabis compound CBD in food and supplements after weighing the evidence on the compound's safety.
The FDA will decide whether regulating legal cannabis will require new agency rules or new legislation from Congress.
Cannabis products, excluding Epidiolex, are illegal at the federal level in the US, although some states allow their use.
According to Patrick Cournoyer, who heads the FDA office developing the agency's cannabis strategy, the FDA will ascertain if CBD can be safely eaten every day for a long period or during pregnancy amid concerns about future fertility.
.


Taiwan Court Fines Tokyo Electron Unit $4.78M in Major TSMC Trade Secrets Case
Lightelligence IPO Soars Over 400% in Hong Kong Debut Amid Rising AI Investment Demand
Gold Prices Fall as Strong Dollar and Rising Oil Prices Pressure Markets
Wall Street Surges to Record Highs Amid Strong Earnings and Economic Stability
Vanda Pharmaceuticals (VNDA) Stock Soars After FDA Approves BYSANTI for Bipolar I and Schizophrenia
US-Iran Conflict Escalates Amid Oil Blockade and Rising Global Tensions
Argentina Court Upholds Cristina Kirchner Asset Seizure in Corruption Case
Panama Defends Port Takeover Amid U.S.-China Tensions and Canal Dispute
Federal Appeals Court Allows Texas SB4 Immigration Law Enforcement to Proceed
Florida Launches Criminal Probe Into OpenAI Over FSU Shooting Incident
Eli Lilly and Insilico Medicine Forge $2.75 Billion AI-Driven Drug Discovery Deal
Oil Prices Surge Amid U.S.-Iran Tensions and Supply Disruption Fears
Nippon Express Stock Jumps as Elliott Investment Signals Strong Foreign Interest in Japan Logistics Sector
Samsung Reports Record Profit as AI Boom Drives Memory Chip Demand
Air Liquide Q1 Revenue Misses Estimates Amid Currency and Energy Headwinds 



